| Nov 20 |
Capricor wins key EU designations for the lead asset
|
| Nov 20 |
Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency
|
| Nov 16 |
Is Capricor Therapeutics (CAPR) the Best Multibagger Stock to Buy Heading into 2025?
|
| Nov 15 |
Capricor Therapeutics Third Quarter 2024 Earnings: Misses Expectations
|
| Nov 14 |
Q3 2024 Capricor Therapeutics Inc Earnings Call
|
| Nov 14 |
Capricor Therapeutics, Inc. (CAPR) Q3 2024 Earnings Call Transcript
|
| Nov 13 |
Capricor Therapeutics (CAPR) Reports Q3 Loss, Misses Revenue Estimates
|
| Nov 13 |
Capricor Therapeutics GAAP EPS of -$0.38 misses by $0.02, revenue of $2.3M misses by $1.27M
|
| Nov 13 |
Capricor: Q3 Earnings Snapshot
|
| Nov 13 |
Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
|
